Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
3.060
-0.440 (-12.57%)
At close: Nov 13, 2025, 4:00 PM EST
3.060
0.00 (0.00%)
After-hours: Nov 13, 2025, 5:15 PM EST

Atea Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
-147.03-168.39-135.96-115.91121.19-10.95
Upgrade
Depreciation & Amortization
0.420.420.420.260.030.02
Upgrade
Loss (Gain) From Sale of Investments
-6.85-11.82-15.45-5.47--
Upgrade
Stock-Based Compensation
30.4351.7749.4346.7239.627.46
Upgrade
Change in Accounts Receivable
------5.82
Upgrade
Change in Accounts Payable
-2.270.211.7-1.9810.29-0.49
Upgrade
Change in Unearned Revenue
-----301.37301.37
Upgrade
Change in Other Net Operating Assets
-8.91-7.6814.46-44.643.235.14
Upgrade
Operating Cash Flow
-134.21-135.5-85.4-120.98-87.01296.73
Upgrade
Capital Expenditures
----1.94-0-0.03
Upgrade
Investment in Securities
138.8356.1140.3-453.47--
Upgrade
Investing Cash Flow
138.8356.1140.3-455.41-0-0.03
Upgrade
Issuance of Common Stock
0.260.270.260.371.47317.63
Upgrade
Other Financing Activities
------0.02
Upgrade
Financing Cash Flow
-25.750.270.260.371.47531.75
Upgrade
Net Cash Flow
-21.12-79.13-44.84-576.02-85.54828.46
Upgrade
Free Cash Flow
-134.21-135.5-85.4-122.93-87.01296.71
Upgrade
Free Cash Flow Margin
-----24.76%610.10%
Upgrade
Free Cash Flow Per Share
-1.61-1.61-1.02-1.48-0.9913.74
Upgrade
Levered Free Cash Flow
-76.44-39.55-9.76-69.52-127.65300.81
Upgrade
Unlevered Free Cash Flow
-76.44-39.55-9.76-69.52-127.65300.81
Upgrade
Change in Working Capital
-11.18-7.4816.16-46.59-247.85300.21
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q